We are located at A Working Lab - Innomedicum on the Karolinska Institute campus in Stockholm, Sweden.
Elypta AB, Nanna Svartz väg 4, 171 65 Solna, Sweden
Elypta is a Swedish molecular diagnostics company focused on reducing cancer mortality through early detection. Elypta is pioneering a metabolism-based liquid biopsy and measures the GAGome as system biomarkers of tumor metabolism. Machine learning algorithms are then used to detect signatures of cancer noninvasively. Elypta is advancing a broad clinical program with core indications in multi-cancer early detection and surveillance of recurrence in renal cell carcinoma.
